CRH Medical Corporation (CRHM) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
57B - 999 CANADA PLACE VANCOUVER, BC V6C 3E1 |
| State of Incorp. | BC |
| Fiscal Year End | December 31 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 5,099 | 5,237 | 13,328 | 6,569 | 5,215 | 2,562 | |||
| Cash and cash equivalents | 5,099 | 5,237 | 13,328 | 6,569 | 5,215 | 2,562 | |||
| Receivables | 3,253 | 1,881 | 2,710 | 1,332 | 2,425 | 2,385 | |||
| Inventory, net of allowances, customer advances and progress billings | 296 | 265 | 323 | 349 | 357 | 511 | |||
| Inventory | 296 | 265 | 323 | 349 | 357 | 511 | |||
| Other undisclosed current assets | 20,786 | 18,167 | 17,867 | 20,771 | 20,086 | 19,845 | |||
| Total current assets: | 29,435 | 25,550 | 34,227 | 29,021 | 28,084 | 25,304 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 202 | 217 | 224 | 252 | 267 | 290 | |||
| Long-term investments and receivables | 324 | 339 | |||||||
| Long-term investments | 324 | 339 | |||||||
| Intangible assets, net (including goodwill) | 168,325 | 155,661 | 153,729 | 163,108 | 157,806 | 170,632 | |||
| Intangible assets, net (excluding goodwill) | 168,325 | 155,661 | 153,729 | 163,108 | 157,806 | 170,632 | |||
| Deferred income tax assets | 12,945 | 12,055 | |||||||
| Other undisclosed noncurrent assets | 3,340 | 454 | 11,160 | 10,714 | 9,952 | 8,662 | |||
| Total noncurrent assets: | 184,812 | 168,386 | 165,113 | 174,074 | 168,350 | 179,924 | |||
| TOTAL ASSETS: | 214,247 | 193,936 | 199,340 | 203,095 | 196,433 | 205,227 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 7,449 | 8,109 | 4,803 | 6,197 | 6,477 | 5,939 | |||
| Accrued liabilities | 5,465 | 4,505 | 3,744 | 4,983 | 4,921 | 4,709 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,984 | 3,604 | 1,058 | 1,213 | 1,556 | 1,230 | |||
| Debt | 221 | 249 | 142 | 194 | 209 | 2,286 | |||
| Deferred compensation liability | 65 | 1,402 | 1,868 | 1,173 | 1,163 | ||||
| Other undisclosed current liabilities | 3,524 | 1,855 | 2,016 | 2,084 | 2,062 | 1,956 | |||
| Total current liabilities: | 11,194 | 10,278 | 8,363 | 10,343 | 9,921 | 11,343 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 75,863 | 65,562 | 70,473 | 68,435 | 68,213 | 64,500 | |||
| Long-term debt, excluding current maturities | 74,997 | 65,525 | 70,437 | 68,380 | 68,145 | 64,500 | |||
| Liabilities, other than long-term debt | 24 | 102 | 22 | ||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 22 | ||
| Deferred income tax liabilities | 24 | 102 | |||||||
| Operating lease, liability | 865 | 37 | 37 | 54 | 67 | ||||
| Other undisclosed noncurrent liabilities | 2,709 | 294 | 102 | 102 | 22 | 80 | |||
| Total noncurrent liabilities: | 78,595 | 65,958 | 70,575 | 68,536 | 68,235 | 64,602 | |||
| Total liabilities: | 89,789 | 76,236 | 78,938 | 78,880 | 78,156 | 75,945 | |||
| Equity | |||||||||
| Equity, attributable to parent | 72,274 | 72,255 | 74,785 | 76,312 | 75,103 | 75,513 | |||
| Common stock | 56,269 | 56,239 | 56,135 | 56,056 | 55,598 | 55,742 | |||
| Additional paid in capital | 8,649 | 8,124 | 7,708 | 7,168 | 7,065 | 7,493 | |||
| Accumulated other comprehensive loss | (67) | (67) | (67) | (67) | (67) | (67) | |||
| Retained earnings (accumulated deficit) | 7,423 | 7,960 | 11,008 | 13,155 | 12,507 | 12,344 | |||
| Equity, attributable to noncontrolling interest | 52,184 | 45,445 | 45,617 | 47,903 | 43,174 | 53,769 | |||
| Total equity: | 124,458 | 117,700 | 120,402 | 124,215 | 118,277 | 129,282 | |||
| TOTAL LIABILITIES AND EQUITY: | 214,247 | 193,936 | 199,340 | 203,095 | 196,433 | 205,227 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 30,349 | 13,585 | 25,455 | 30,369 | 30,415 | 30,482 | ||
| Other income | 290 | 4,857 | ||||||
| Cost of revenue (Cost of Goods and Services Sold) | (30,265) | (21,634) | (28,052) | (27,812) | (26,702) | (25,895) | ||
| Gross profit: | 85 | (8,049) | (2,597) | 2,558 | 3,713 | 4,587 | ||
| Operating income (loss): | 85 | (8,049) | (2,597) | 2,558 | 3,713 | 4,587 | ||
| Nonoperating expense | (497) | (913) | (1,125) | (2,179) | ||||
| Gain (loss), foreign currency transaction, before tax | 2 | (8) | 0 | (3) | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 85 | (8,049) | (3,094) | 1,644 | 2,587 | 2,408 | ||
| Income (loss) from equity method investments | (22) | (16) | 1,350 | 77 | 214 | |||
| Other undisclosed income (loss) from continuing operations before income taxes | (152) | 4,410 | ||||||
| Income (loss) from continuing operations before income taxes: | (67) | (3,662) | (3,109) | 2,995 | 2,664 | 2,622 | ||
| Income tax expense (benefit) | 376 | 234 | 974 | (891) | (565) | (4) | ||
| Income (loss) from continuing operations: | 309 | (3,428) | (2,135) | 2,104 | 2,099 | 2,619 | ||
| Income (loss) before gain (loss) on sale of properties: | 309 | (3,428) | (2,135) | 2,104 | 2,099 | 2,619 | ||
| Net income (loss): | 309 | (3,428) | (2,135) | 2,104 | 2,099 | 2,619 | ||
| Net income (loss) attributable to noncontrolling interest | (647) | 521 | 56 | (885) | (1,117) | (972) | ||
| Net income (loss) available to common stockholders, diluted: | (338) | (2,908) | (2,078) | 1,219 | 982 | 1,647 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 309 | (3,428) | (2,135) | 2,104 | 2,099 | 2,619 | ||
| Comprehensive income (loss): | 309 | (3,428) | (2,135) | 2,104 | 2,099 | 2,619 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (647) | 521 | 56 | (885) | (1,117) | (972) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 647 | (521) | (56) | 4,441 | 1,117 | 972 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 309 | (3,428) | (2,135) | 5,660 | 2,099 | 2,619 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.